Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,422,904 shares of AMPH stock, worth $61.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,422,904

Previous 2,714,628 10.75%

Holding current value

$61.2 Million

Previous $101 Million 30.31%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$26.24 - $38.48 $7.65 Million - $11.2 Million	-291,724 Reduced 10.75%	2,422,904 $70.2 Million
Q4 2024 Feb 11, 2025	BUY	$36.84 - $53.4 $116,230 - $168,477	3,155 Added 0.12%	2,714,628 $101 Million
Q3 2024 Nov 13, 2024	BUY	$36.99 - $50.09 $1.43 Million - $1.93 Million	38,611 Added 1.44%	2,711,473 $132 Million
Q2 2024 Aug 13, 2024	SELL	$38.65 - $43.48 $2.36 Million - $2.66 Million	-61,178 Reduced 2.24%	2,672,862 $107 Million
Q1 2024 May 10, 2024	SELL	$42.85 - $63.45 $3.49 Million - $5.17 Million	-81,556 Reduced 2.9%	2,734,040 $120 Million
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $2.14 Million - $3.03 Million	48,203 Added 1.74%	2,815,596 $174 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $282,890 - $404,040	-6,216 Reduced 0.22%	2,767,393 $127 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $4.36 Million - $7.12 Million	122,004 Added 4.6%	2,773,609 $159 Million
Q1 2023 Jul 14, 2023	BUY	$27.99 - $37.92 $24,799 - $33,597	886 Added 0.03%	2,651,605 $99.4 Million
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $809,246 - $1.1 Million	28,912 Added 1.1%	2,650,719 $99.4 Million
Q4 2022 Feb 10, 2023	BUY	$27.93 - $31.27 $436,964 - $489,219	15,645 Added 0.6%	2,621,807 $73.5 Million
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $1.25 Million - $1.71 Million	45,385 Added 1.77%	2,606,162 $73.2 Million
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $2.31 Million - $3.28 Million	77,572 Added 3.12%	2,560,777 $89.1 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $346,558 - $550,176	15,094 Added 0.61%	2,483,205 $89.1 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $988,865 - $1.27 Million	-54,513 Reduced 2.16%	2,468,111 $57.5 Million
Q3 2021 Nov 12, 2021	BUY	$17.83 - $21.49 $1.12 Million - $1.35 Million	62,893 Added 2.56%	2,522,624 $48 Million
Q2 2021 Aug 13, 2021	BUY	$17.11 - $20.92 $42.1 Million - $51.5 Million	2,459,731 New	2,459,731 $49.6 Million

Others Institutions Holding AMPH

# of Institutions

258

Shares Held

33.6M

Call Options Held

20.8K

Put Options Held

11.6K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.24B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Transaction History